BioNxt Solutions (BXT) Stock Statistics & Valuation Metrics
Total Valuation
BioNxt Solutions has a market cap or net worth of EUR 22.67M. The enterprise value is EUR 49.67M.
- Market Cap
- EUR 22.67M
- Enterprise Value
- EUR 49.67M
Share Statistics
BioNxt Solutions has 136,093,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 136,093,150
- Owned by Insiders
- 1.65%
- Owned by Institutions
- ―
Financial Efficiency
BioNxt Solutions’s return on equity (ROE) is 0.75 and return on invested capital (ROIC) is 172.18%.
- Return on Equity (ROE)
- 0.75
- Return on Assets (ROA)
- -11.87
- Return on Invested Capital (ROIC)
- 172.18%
- Return on Capital Employed (ROCE)
- 1.12
- Revenue Per Employee
- 0
- Profits Per Employee
- -281.02K
- Employee Count
- 25
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of BioNxt Solutions is -3.52. BioNxt Solutions’s PEG ratio is 0.10.
- PE Ratio
- -3.52
- PS Ratio
- 0.00
- PB Ratio
- -5.40
- Price to FCF
- -7.77
- Price to Operating Cash Flow
- -7.42
- PEG Ratio
- 0.10
Income Statement
In the last 12 months, BioNxt Solutions had revenue of 0 and earned -7.03M in profits. Earnings per share was -0.06.
- Revenue
- 0
- Gross Profit
- -10.90K
- Operating Income
- -6.05M
- Pretax Income
- -7.22M
- Net Income
- -7.03M
- EBITDA
- -6.04M
- Earnings Per Share (EPS)
- -0.06
Cash Flow
In the last 12 months, operating cash flow was -4.55M and capital expenditures 4, giving a free cash flow of -4.55M billion.
- Operating Cash Flow
- -4.55M
- Free Cash Flow
- -4.55M
- Free Cash Flow per Share
- -0.04
Dividends & Yields
BioNxt Solutions pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -12.87%
- Earnings Yield
- -27.05%
Stock Price Statistics
- Beta
- 0.61
- 52-Week Price Change
- -63.51%
- 50-Day Moving Average
- 0.21
- 200-Day Moving Average
- 0.27
- Relative Strength Index (RSI)
- 42.79
- Average Volume (3m)
- 27.22K
Important Dates
BioNxt Solutions upcoming earnings date is Nov 27, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 28, 2026
- Next Earnings Date
- Nov 27, 2026
- Ex-Dividend Date
- ―
Financial Position
BioNxt Solutions as a current ratio of 0.05, with Debt / Equity ratio of -63.50%
- Current Ratio
- 0.05
- Quick Ratio
- 0.05
- Debt to Market Cap
- 0.08
- Net Debt to EBITDA
- -0.98
- Interest Coverage Ratio
- -4.20
Taxes
In the past 12 months, BioNxt Solutions has paid -197.47K in taxes.
- Income Tax
- -197.47K
- Effective Tax Rate
- 0.03
Enterprise Valuation
BioNxt Solutions EV to EBITDA ratio is -4.97, with an EV/FCF ratio of -8.97.
- EV to Sales
- 0.00
- EV to EBITDA
- -4.97
- EV to Free Cash Flow
- -8.97
- EV to Operating Cash Flow
- -8.97
Balance Sheet
BioNxt Solutions has EUR 1.20M in cash and marketable securities with EUR 6.69M in debt, giving a net cash position of -EUR 5.48M billion.
- Cash & Marketable Securities
- EUR 1.20M
- Total Debt
- EUR 6.69M
- Net Cash
- -EUR 5.48M
- Net Cash Per Share
- -EUR 0.04
- Tangible Book Value Per Share
- -EUR 0.05
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
